These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 32619494)
1. Induced Fetal Human Muscle Stem Cells with High Therapeutic Potential in a Mouse Muscular Dystrophy Model. Zhao M; Tazumi A; Takayama S; Takenaka-Ninagawa N; Nalbandian M; Nagai M; Nakamura Y; Nakasa M; Watanabe A; Ikeya M; Hotta A; Ito Y; Sato T; Sakurai H Stem Cell Reports; 2020 Jul; 15(1):80-94. PubMed ID: 32619494 [TBL] [Abstract][Full Text] [Related]
2. iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling. Guo D; Daman K; Chen JJ; Shi MJ; Yan J; Matijasevic Z; Rickard AM; Bennett MH; Kiselyov A; Zhou H; Bang AG; Wagner KR; Maehr R; King OD; Hayward LJ; Emerson CP Elife; 2022 Jan; 11():. PubMed ID: 35076017 [TBL] [Abstract][Full Text] [Related]
3. Core Transcription Factors Promote Induction of PAX3-Positive Skeletal Muscle Stem Cells. Sato T; Higashioka K; Sakurai H; Yamamoto T; Goshima N; Ueno M; Sotozono C Stem Cell Reports; 2019 Aug; 13(2):352-365. PubMed ID: 31353225 [TBL] [Abstract][Full Text] [Related]
4. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy. He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065 [TBL] [Abstract][Full Text] [Related]
5. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle. Lala-Tabbert N; Fu D; Wiper-Bergeron N Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360 [TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy. Domenig SA; Bundschuh N; Lenardič A; Ghosh A; Kim I; Qabrati X; D'Hulst G; Bar-Nur O Stem Cell Reports; 2022 Feb; 17(2):321-336. PubMed ID: 34995499 [TBL] [Abstract][Full Text] [Related]
7. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy. Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035 [TBL] [Abstract][Full Text] [Related]
8. AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice. Nance ME; Shi R; Hakim CH; Wasala NB; Yue Y; Pan X; Zhang T; Robinson CA; Duan SX; Yao G; Yang NN; Chen SJ; Wagner KR; Gersbach CA; Duan D Mol Ther; 2019 Sep; 27(9):1568-1585. PubMed ID: 31327755 [TBL] [Abstract][Full Text] [Related]
10. Interplay between Pitx2 and Pax7 temporally governs specification of extraocular muscle stem cells. Kuriki M; Korb A; Comai G; Tajbakhsh S PLoS Genet; 2024 Jun; 20(6):e1010935. PubMed ID: 38875306 [TBL] [Abstract][Full Text] [Related]
11. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model. Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519 [TBL] [Abstract][Full Text] [Related]
12. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy. Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607 [TBL] [Abstract][Full Text] [Related]
13. Stem cell-based therapies for Duchenne muscular dystrophy. Sun C; Serra C; Lee G; Wagner KR Exp Neurol; 2020 Jan; 323():113086. PubMed ID: 31639376 [TBL] [Abstract][Full Text] [Related]
14. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro. Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718 [TBL] [Abstract][Full Text] [Related]
15. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures. Haynes P; Kernan K; Zhou SL; Miller DG Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492 [TBL] [Abstract][Full Text] [Related]
16. Characterization of hiPSC-Derived Muscle Progenitors Reveals Distinctive Markers for Myogenic Cell Purification Toward Cell Therapy. Nalbandian M; Zhao M; Sasaki-Honda M; Jonouchi T; Lucena-Cacace A; Mizusawa T; Yasuda M; Yoshida Y; Hotta A; Sakurai H Stem Cell Reports; 2021 Apr; 16(4):883-898. PubMed ID: 33798449 [TBL] [Abstract][Full Text] [Related]
17. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. Gonçalves MA; de Vries AA; Holkers M; van de Watering MJ; van der Velde I; van Nierop GP; Valerio D; Knaän-Shanzer S Hum Mol Genet; 2006 Jan; 15(2):213-21. PubMed ID: 16321987 [TBL] [Abstract][Full Text] [Related]
18. A dual-color PAX7 and MYF5 in vivo reporter to investigate muscle stem cell heterogeneity in regeneration and aging. Ancel S; Michaud J; Sizzano F; Tauzin L; Oliveira M; Migliavacca E; Schüler SC; Raja S; Dammone G; Karaz S; Sánchez-García JL; Metairon S; Jacot G; Bentzinger CF; Feige JN; Stuelsatz P Stem Cell Reports; 2024 Jul; 19(7):1024-1040. PubMed ID: 38876109 [TBL] [Abstract][Full Text] [Related]
20. ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs. Hicks MR; Hiserodt J; Paras K; Fujiwara W; Eskin A; Jan M; Xi H; Young CS; Evseenko D; Nelson SF; Spencer MJ; Handel BV; Pyle AD Nat Cell Biol; 2018 Jan; 20(1):46-57. PubMed ID: 29255171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]